Doxazosin - 0093-2069-01 - (Doxazosin Mesylate)

Alphabetical Index


Drug Information of Doxazosin

Product NDC: 0093-2069
Proprietary Name: Doxazosin
Non Proprietary Name: Doxazosin Mesylate
Active Ingredient(s): 2    mg/1 & nbsp;   Doxazosin Mesylate
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Doxazosin

Product NDC: 0093-2069
Labeler Name: Teva Pharmaceuticals USA Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075536
Marketing Category: ANDA
Start Marketing Date: 20130329

Package Information of Doxazosin

Package NDC: 0093-2069-01
Package Description: 100 TABLET in 1 BOTTLE (0093-2069-01)

NDC Information of Doxazosin

NDC Code 0093-2069-01
Proprietary Name Doxazosin
Package Description 100 TABLET in 1 BOTTLE (0093-2069-01)
Product NDC 0093-2069
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Doxazosin Mesylate
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20130329
Marketing Category Name ANDA
Labeler Name Teva Pharmaceuticals USA Inc
Substance Name DOXAZOSIN MESYLATE
Strength Number 2
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Doxazosin


General Information